Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Peripheral Helper Cells May Provide Clue to RA Pathology

Lara C. Pullen, PhD  |  February 27, 2017

TPH cells are also unique in that they express chemokine receptors, such as CCR2, CXCR1 and CCR5, which direct migration to inflamed sites. Thus, the newly identified T cell population is able to infiltrate parts of the body that are inflamed and stimulate B cells to produce antibodies. In particular, the investigators found that PD-1hiCXCR5–CD4+ T cells that had been sorted from the synovial tissue or fluid of patients with RA could induce differentiation of co-cultured memory B cells into plasma cells. In contrast, CXCR5– cells that did not have high PD-1 expression could not stimulate a B cell response.

The fact that TPH cells are uniquely enriched in seropositive RA implies that they are critical for the T cell-B cell interactions that are characteristic of seropositive disease. “Our results help illuminate a path toward treatment that is much more precise and focused only on the most relevant immune cells,” said Dr. Rao in a press release.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

To that end, the investigators intend to focus their future research on developing a better understanding of the signals required to develop TPH cells, as well as the role these cells may play in other autoimmune diseases. Such studies may reveal whether the presence of TPH cells may be a useful diagnostic biomarker or, alternatively, a predictive biomarker that can be used to identify which patients are most likely to respond to therapies, such as rituximab, that directly target T cell-B cell interactions.

“This work is a remarkable illustration of the power of our disease deconstruction approach,” says senior author Michael B. Brenner, MD, who also directs BWH’s Human Immunology Center with Dr. Rao, in a press release. “We hope it will prove equally illuminating as we apply it to other immune-mediated diseases.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

Reference

  1. Rao DA, Gurish MF, Marshall JL, et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017 Feb 1;542(7639):110–114. doi: 10.1038/nature20810.

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsRheumatoid Arthritis Tagged with:B cellsperipheral helper cellsRheumatoid Arthritis (RA)seropositive RAT cell

Related Articles

    Rheumatology Research Foundation Funding Enables Potential Treatment Advancements

    June 13, 2017

    Investigators at Brigham and Women’s Hospital recently discovered a novel subset of peripheral helper T cells (TPH) that drive rheumatoid arthritis (RA) inflammation. Originally published in the February issue of Nature, findings from this study provided bedrock knowledge for developing new RA therapies. Now, with funding from the Rheumatology Research Foundation, investigators are expanding on…

    Foot Pain a Burden for Rheumatology Patients

    January 13, 2012

    Researchers say it may even correlate with back, hip, and knee pain

    Th 17 Cells and Arthritis

    July 1, 2008

    The true story of how IL-17 became a focus for RA research

    FOCIS 2015: TET Protein Regulation May Provide Insights for Cancer Treatment

    September 15, 2015

    A presentation given during FOCIS 2015, the 15th annual meeting of the Federation of Clinical Immunity Societies in June 2015 in San Diego, focused on advances in stem cell research related to treatment of cancer and the function that particular enzymes play in disease. Anjana Rao, PhD, professor at the La Jolla Institute for Allergy…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences